Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (5)

1

Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies

enthalten in: Journal of hypertension | 2012

von Verdecchia, P. | Dagenais, G. | Healey, J. | +14

CommentIn: J Hypertens. 2012 May;30(5):887-9. - PMID 22495133

2

Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice

enthalten in: Journal of hypertension | 2010

von Iwanami, J. | Mogi, M. | Tsukuda, K. | +5

3

Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats

enthalten in: Journal of hypertension | 2009

von Tamura, T. | Jamous, M. | Kitazato, K. | +4

4

Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia : in-vivo and in-vitro studies

enthalten in: Journal of hypertension | 2008

von Liu, H. | Kitazato, K. | Uno, M. | +6

5

Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan

enthalten in: Journal of hypertension | 1999

von Azizi, M. | Chatellier, G. | Guyene, T. | +1

1
[1]